MoneyToday released a CEO interview article on the newspaper and online yesterday (In Korean only: https://news.mt.co.kr/mtview.php?no=2021072014373786320, https://news.mt.co.kr/mtview.php?no=2021072014461679862)

Reporter Kim focused on EOFlow's newly established pharmaceutical subsidiary 'Pharmeo'.
EOFlow's CEO Jesse Kim expected the drug delivery business as a momentum to exceed global competitors. 
Jesse also explained the other subsidiary 'Nephria Bio' which develops wearable artificial kidneys.